Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial

Mitzi M. Gonzales, Valentina Rose Garbarino, Eduardo Marques Zilli, Ronald Carl Petersen, James L. Kirkland, Tamar Tchkonia, Nicolas Musi, Sudha S. Seshadri, Suzanne Craft, Miranda E. Orr
ISSN / E-ISSN
— / —
DOI
10.14283/jpad.2021.62 ↗
Volume · Issue · Pages
9 · 1 · 22-29
Publisher
Springer International Publishing AG
Article URL
https://doi.org/10.14283/jpad.2021.62 ↗
Article details
Unverified
Publication date (each date has its type and source)
22 Nov 2021
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date22 Nov 2021 OpenAlex

Keywords (as given): senolytic therapy; Alzheimer's disease; dasatinib; quercetin; cellular senescence; tau accumulation; tauopathy; intermittent dosing; cerebrospinal fluid drug penetration; neuroinflammation; cognitive decline; early Alzheimer's disease; older adults

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized Y
Based on the recorded HEC dataset applicable to the article's publication date. Listed as Y in the HEC list for hjrs 2021-22 V2.
Journal
journal of prevention of Alzheimer's disease, The
Publication date used
22 Nov 2021 (OpenAlex publication date)
Applicable HEC period
hjrs 2021-22 V2 (version 1) · 01 Jul 2021 – 30 Jun 2022
Category
Y
Recognition status
Recognized (OK_RECORD_FOUND)
Source
hjrs-2021-22 row 3432
Verification status
Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.